Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Akers Biosciences, Inc.    AKER

AKERS BIOSCIENCES, INC.

(AKER)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société AKERS BIOSCIENCES, INC.
2020AKERS BIOSCIENCES INVESTOR ALERT BY : Kahn Swick & Foti, LLC Investigates Merge..
BU
2020AKERS BIOSCIENCES : ' Proposed Merger Partner MyMD Pharmaceuticals Announces Iss..
BU
2020AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
2020AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
2020REMINDER : Akers Biosciences Schedules Conference Call to Discuss Merger with My..
BU
2020AKERS BIOSCIENCES INVESTOR ALERT BY : Kahn Swick & Foti, LLC Investigates Merge..
BU
2020AKERS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition ..
AQ
2020AKERS BIOSCIENCES, INC. : Other Events (form 8-K)
AQ
2020AKERS BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered Sal..
AQ
2020AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister..
AQ
2020AKERS MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Wheth..
BU
2020AKERS BIOSCIENCES : and MyMD Pharmaceuticals Sign Definitive Merger Agreement
BU
2020AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Material M..
AQ
2020AKERS BIOSCIENCES : Change in Directors or Principal Officers, Submission of Mat..
AQ
2020AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Submission ..
AQ
2020AKERS BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exh..
AQ
2020AKERS BIOSCIENCES : Quarterly report
PU
2020AKERS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition ..
AQ
2020AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister..
AQ
2020AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister..
AQ
2020AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Amendments ..
AQ
2020AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial S..
AQ
2020AKERS BIOSCIENCES, INC. : Shareholder Director Nominations (form 8-K)
AQ
2020AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
2020AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
2020AKERS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition ..
AQ
2020AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister..
AQ
2020AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Even..
AQ
2020AKERS BIOSCIENCES : and Premas Biotech Announce Successful Completion of Vaccine..
AQ
2020Here's How Akers Biosciences and Premas Biotech Plan To Knock Out COVID-19 Vi..
NE
2020AKERS BIOSCIENCES, INC. : Other Events (form 8-K)
AQ
2020AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
2020AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister..
AQ
2020AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form ..
AQ
2020AKERS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition ..
AQ
2020AKERS BIOSCIENCES : Schedules Conference Call to Discuss Licensing Announcement ..
AQ
2020AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister..
AQ
2020AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
2020AKERS BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exh..
AQ
2020AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Amendments ..
AQ
2019AKERS BIOSCIENCES : Announces Closing of Approximately $8 Million Public Offerin..
AQ
2019AKERS BIOSCIENCES, INC. : Other Events (form 8-K)
AQ
2019AKERS BIOSCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fi..
AQ
2019Akers Biosciences Reports Fiscal Year 2018 Earnings
GL
2019AKERS BIOSCIENCES : Cancellation - Akers Biosciences, Inc.
PU
2019AKERS BIOSCIENCES : Result of Special Meeting of Shareholders
PU
2019AKERS BIOSCIENCES : Holding in Company
PU
2019AKERS BIOSCIENCES : Form DEFA14A Filing - Additional Proxy Materials
PU
2019AKERS BIOSCIENCES : Notice of Special Meeting of Shareholders
PU
2019AKERS BIOSCIENCES : Further Re. Directorate Change
PU
2018AKERS BIOSCIENCES : Intention to Delist from AIM
PU
2018AKERS BIOSCIENCES : Result of AGM & Form 8-K Filing
PU
2018AKERS BIOSCIENCES : Further Re. Notice of AGM
PU
2018AKERS BIOSCIENCES : Further Re. Strategic Update
PU
2018AKERS BIOSCIENCES : Reverse Stock Split Update
PU
2018Akers Biosciences Announces Q3 2018 Earnings
GL
2018AKERS BIOSCIENCES : 3rd Quarter 2018 Results
PU
2018AKERS BIOSCIENCES : Notice of AGM
PU
2018AKERS BIOSCIENCES : Form 8-K Filing
PU